YM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levels

Cisplatin is one of the commonly used chemotherapeutic drugs for the treatment of head and neck squamous cell carcinoma (HNSCC). However, acquisition of cisplatin resistance is common in patients with HNSCC and it often leads to local and distant failure. In this study, we demonstrate that survivin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kumar, Bhavna, Yadav, Arti, Lang, James C., Cipolla, Michael, Schmitt, Alessandra C., Arradaza, Nicole, Teknos, Theodoros N., Kumar, Pawan
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889136/
https://ncbi.nlm.nih.gov/pubmed/22723337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0167
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares